Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000134

Pres. Diagnostics & Genom gave up 856 shares (to pay taxes)

  • Pres. Diagnostics & Genom acquired 1,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Pres. Diagnostics & Genom

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-01 Exercise or conversion : show line 1 in the form +1,667 2,512 D
2021-05-01 Shares withheld for taxes : show line 2 in the form −856 $427.49 $365,931 1,656 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,667 0 D
Loading xslF345X03/edgar.xml…